Who we are
The HCV Action Steering Group members include consultant hepatologists, hepatitis C nurse specialists, GPs with a special interest in hepatology, patients and pharmaceutical industry representatives. The administration costs of HCV Action are funded by pharmaceutical industry partners, and The Hepatitis C Trust provides secretariat support.
Members of the HCV Action Steering Committee
Dr Steve Ryder (Chair), Consultant Hepatologist, Nottingham University Hospitals NHS Trust and Biomedical Research Unit
Dr Steve Ryder chairs the HCV Action steering committee. He has worked as a consultant hepatologist in Nottingham since 1994, focusing on the therapy of hepatitis B and C infections and treatment of liver cancer. He has a research interest in the natural history of liver fibrosis in chronic hepatitis C infection, and is a major contributor to the Trent HCV Cohort study, informing several HPA reports and national strategy on hepatitis C management. Dr Ryder is the national lead for the Hepatology Special Interest group of the Clinical Research Network, with a significant role in co-ordinating and ensuring patient access to clinical trials for new hepatitis C therapies across the UK. He trained at St Mary’s Hospital and Kings College Hospital, London.
Dr Ken Armstrong, GP, Durham
Dr Armstrong studied medicine at Queens University, Belfast and qualified in 1988. As a junior doctor preparing for General Practice he spent extra time doing psychiatry attachments and obtained a diploma in mental health, becoming involved in the treatment of patients who engaged in substance misuse. He moved to England in 1999, and with three other GPs established a substance misuse clinic. As a result of this work he became particularly interested in hepatitis C and how GPs can become better educated about diagnosis and treatment.
Charles Gore, Chief Executive of The Hepatitis C Trust
Charles is Chief Executive of The Hepatitis C Trust, which he founded in 2001. He is considered a foremost authority on hepatitis C. Charles was the first President of the European Liver Patients Association in 2004 -2006 and has been the expert patient witness for two National Institute of Health and Clinical Excellence technology appraisals. He was a consultee to the Skipton Fund and a founding trustee of the Caxton Foundation, set up to administer discretionary payments to those who were infected with hepatitis C through the NHS. He was a consultee to the Scottish Government and to the Welsh Public Health Service for their respective Hepatitis C Action Plans and was involved in developing the Department of Health’s Liver Strategy, as well as authoring two reports auditing the National Health Service's implementation of the English Hepatitis C Action Plan. Charles has been the driving force behind establishing World Hepatitis Day and was elected President of the World Hepatitis Alliance, the umbrella organisation working with some 200 patient groups worldwide.
Kate Jack, Advanced Virology Nurse Specialist, Nottingham
Kate Jack has over 23 years professional experience in nursing, notably as a Clinical Nurse Specialist in Viral Hepatitis at the Leicester Royal Infirmary and as an Advanced Virology Nurse Specialist at Nottingham University Hospitals NHS Trust. Kate is a Master of Public Health and a tutor for the Royal College of General Practitioners’ certificate in the detection, diagnosis and management of hepatitis B and C in primary care, parts 1 and 2. She was involved in the development of the RCGP Guide to the Management of Hepatitis C in General Practice (2007) and has co-authored papers including ‘Hepatitis C therapy at home: A hospital and home care partnership’ for the British Journal of Nursing. Kate is currently on secondment to undertake an NIHR-funded Masters in Research Methodology, and is working as a research nurse on a study of injecting drug users undertaking hepatitis C antiviral treatment.
Dr Stephen Willott, GP, Nottingham
Dr Stephen Willott leads on GP engagement for HCV Action. He is a GP in inner-city Nottingham, where he also works for NHS Nottingham City as the clinical lead for drug and alcohol misuse. As a GP and working at the Nottingham Friary Drop-In centre for the homeless, Dr Willott regularly sees patients at high risk of blood-borne virus infection including hepatitis C. By offering testing, treatment and support in the community, he has helped to address issues of inequality and social exclusion among the 180 drug users that attend the drop-in, of whom around 25% have hepatitis C. He is vice chair and drugs lead for the RCGP Sex, Drugs and BBV group, and holds part one and two of the RCGP hepatitis C certificate. At the beginning of the millennium, he spent 3 years in Thailand establishing an HIV/AIDS programme in Monorom Christian Hospital, Chainat.
Helen Hampton, BBV Lead Nurse, Addaction
In 2004 Helen Hampton qualified as a Registered General Nurse in her home county of Cornwall. She worked at the Royal Cornwall Hospital (RCH) as a surgical nurse on the vascular ward and the surgical admissions unit.
Helen worked with Cornwall Drug and Alcohol Team (2007-2012) running a successful HCV treatment service in primary care offering treatment and support to a community that can feel isolated, marginalised and socially excluded. In 2012 she joined Addaction in a new developing role and has an honorary prescribing contract with RCH enabling her to continue with her passion: treating HCV in the community.
Helen was presented with a 'highly commended' certificate on behalf of the team for 'best treatment pathway initiative' at the Quality in Care 2014 Hepatitis C awards. In 2015 she was awarded the Queen's Nurse Title in recognition of her community work.